Event: Accelerate Small Molecule Development with Smart Formulation & Funding Strategies
Date: 4 June 2025; 10:00 am - 5:00 pm
Location: The Royal Society of Chemistry Burlington House, Piccadilly, London W1J 0BA
Event Overview
The future of small molecule development is being redefined. But with innovation comes complexity including formulation challenges, developability roadblocks, tight timelines and limited resources. For early-stage pharma companies, the stakes are high; missteps can lead to costly delays, regulatory setbacks, and missed market opportunities.
Why Attend
Join industry experts as we break down the critical phases of small molecule development, covering formulation strategies, scalable manufacturing solutions, and CMC best practices to accelerate your path to the clinic. Beyond the science, we’ll tackle the drug development business, including aligning with investor expectations and securing funding in a competitive landscape. Gain the insights, tools, and connections you need to de-risk development, optimize your strategy, and fast-track your innovation to market success. Plus, take advantage of exclusive 1:1 office hours with our experts to discuss your molecule challenges.
Key Learning Objectives
Understand the key steps for advancing a drug from preclinical to First-In-Human trials while meeting regulatory requirements.
Learn data-driven strategies to anticipate formulation and manufacturing challenges and accelerate clinical entry.
Gain practical insights into securing venture capital funding, tailored for emerging pharma startups.
Who Should Attend
Professionals in Preclinical & Formulation Development, CMC, Drug Substance & Product Development, Project Management, Manufacturing & Operations, Supply Chain Management, and pharma consultants seeking a CDMO partner for developing and manufacturing oral solid dosage forms.
Join us now!